Ampyra for Multiple Sclerosis User Reviews (Page 4)
Ampyra has an average rating of 8.0 out of 10 from a total of 71 reviews for the treatment of Multiple Sclerosis. 73% of reviewers reported a positive experience, while 13% reported a negative experience.
Reviews for Ampyra
- Mar...
- Taken for 6 months to 1 year
- January 11, 2022
"I developed kidney stones after several months on this. After stopping it for 6 months, they went away and never came back again. It did nothing for my walking."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Multiple Sclerosis
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about Ampyra (dalfampridine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
"I've been on this medicine for 4 years and am doing really good!!"